Evaluation of the Turkish Population's Perspective on COVID-19 Vaccine Hesitancy and Routine Childhood Vaccine Applications: National Survey Study

dc.authoridBOZ, GULSEDA/0000-0003-1959-0226
dc.authoridözer, ali/0000-0002-7144-4915
dc.authoridÇOLAK, CEMİL/0000-0001-5406-098X
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridSAHIN, TEVFIK TOLGA/0000-0002-9132-6115
dc.authorwosidBOZ, GULSEDA/ACH-3821-2022
dc.authorwosidözer, ali/ABI-2209-2020
dc.authorwosidÇOLAK, CEMİL/ABI-3261-2020
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.authorwosidSAHIN, TEVFIK TOLGA/W-2539-2017
dc.contributor.authorAkbulut, Sami
dc.contributor.authorBoz, Gulseda
dc.contributor.authorOzer, Ali
dc.contributor.authorSahin, Tevfik Tolga
dc.contributor.authorColak, Cemil
dc.date.accessioned2024-08-04T20:53:40Z
dc.date.available2024-08-04T20:53:40Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: It is important to evaluate the attitude of society towards vaccines to understand the rates of acceptance and hesitance towards vaccination, which are essential components of public health and epidemiology. This study aimed to evaluate the perspective of the Turkish population on COVID-19 status, rate of vaccination, and also to evaluate the reasons for refusal to vaccinate, vaccine hesitancy, and related factors. Methods: A total of 4539 participants were included in this population-based descriptive and cross-sectional study. The Nomenclature of Territorial Units for Statistics (NUTS-II) was used to obtain a representative sample and for this purpose Turkey was divided into 26 regions. Participants were randomly selected based on the demographic features and population ratios of the selected regions. The following parameters were evaluated: sociodemographic characteristics and perspectives on COVID-19 vaccines, Vaccine Hesitancy Scale Adapted to Pandemics (VHS-P), and Anti-Vaccine Scale-Long Form (AVS-LF) questions. Results: A total of 4539 participants, 2303 (50.7%) male and 2236 (49.3%) female, aged between 18 and 73 years, were included in this study. It was observed that 58.4% of the participants had hesitations towards COVID-19 vaccination, and 19.6% were hesitant about all childhood vaccinations. Those who did not have the COVID-19 vaccine, who did not think that the COVID-19 vaccine was protective, and who had hesitation to vaccinate against COVID-19 had significantly higher median scores on the VHS-P and AVS-LF scales, respectively (all p < 0.01). Those who did not have their children vaccinated in childhood and who were hesitant about childhood vaccinations, had significantly higher median scores on the VHS-P and AVS-LF scales, respectively (all p < 0.01). Conclusion: Although the rate of vaccination for COVID-19 was 93.4% in the study, hesitation to vaccinate was 58.4%. The median score of the scales of those who were hesitant about childhood vaccinations was higher than individuals who did not have any hesitation. In general, the source of concerns about vaccines should be clearly seen, and precautions should be taken.en_US
dc.identifier.doi10.3390/vaccines11040779
dc.identifier.issn2076-393X
dc.identifier.issue4en_US
dc.identifier.pmid37112690en_US
dc.identifier.scopus2-s2.0-85153748142en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.urihttps://doi.org/10.3390/vaccines11040779
dc.identifier.urihttps://hdl.handle.net/11616/101320
dc.identifier.volume11en_US
dc.identifier.wosWOS:000978353300001en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMdpien_US
dc.relation.ispartofVaccinesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectpublic healthen_US
dc.subjectvaccine hesitancyen_US
dc.subjectanti-vaccinationen_US
dc.subjectchildhood vaccinationsen_US
dc.titleEvaluation of the Turkish Population's Perspective on COVID-19 Vaccine Hesitancy and Routine Childhood Vaccine Applications: National Survey Studyen_US
dc.typeArticleen_US

Dosyalar